Mease, Philip
van der Heijde, Désirée
Kirkham, Bruce
Schett, Georg
Orbai, Ana-Maria
Ritchlin, Christopher
Merola, Joseph F.
Pricop, Luminita
James, David A.
Zhu, Xuan
Ligozio, Gregory
Article History
Received: 8 February 2022
Accepted: 3 November 2022
First Online: 28 December 2022
Declarations
:
: Not applicable
: Not applicable
: PM has received grants and/or has acted as consultant/speaker from the following companies: AbbVie, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Eli Lilly, Merck, Novartis, Pfizer, SUN Pharma, and UCB. DvdH received personal fees from Novartis, AbbVie, Bayer, BMS, Cyxone, Eisai, Galapagos, Gilead, GlaxoSmithKline, Janssen, Lilly, Pfizer, UCB Pharma, and Director of Imaging Rheumatology BV. BK received research grants, consultation fees, or speaker honoraria from AbbVie, BMS, Celgene, Janssen, Eli Lilly, MSD, Novartis, Roche, Gilead, and UCB. GS has received speaker fee from AbbVie, BMS, Celgene, Janssen, Lilly, Novartis, Roche, and UCB. AMO has received research grant support to Johns Hopkins University from AbbVie, Amgen, Celgene, Eli Lilly, Gilead, Horizon, Janssen, and Novartis, and received personal consulting fees from Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. CR has received consulting fees from AbbVie, Amgen, Eli Lilly, Janssen, Pfizer, Novartis, Gilead, and UCB. JFM was a consultant and/or investigator for Amgen, Bristol Myers Squibb, AbbVie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Sanofi, Regeneron, SUN Pharma, Biogen, Pfizer, and Leo Pharma. LP, DAJ, XZ and GL are employees of Novartis, and may own Novartis stock.